Elucidating the 'Jekyll and Hyde' Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists

被引:54
作者
Biswas, Arunima [1 ]
Mani, Sridhar [1 ]
Redinbo, Matthew R. [2 ]
Krasowski, Matthew D. [3 ]
Li, Hao [1 ]
Ekins, Sean [4 ,5 ,6 ]
机构
[1] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[2] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
[3] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[4] Collaborat Drug Discovery Inc, Burlingame, CA 94010 USA
[5] Univ Maryland, Dept Pharmaceut Sci, College Pk, MD 21201 USA
[6] Univ Med & Dent New Jersey, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
关键词
agonists; antagonists; machine learning; pharmacophore; pregnane X receptor; PREGNANE-X-RECEPTOR; ST-JOHNS-WORT; CONSTITUTIVE-ANDROSTANE RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; DHR78 NUCLEAR RECEPTOR; BILE-ACID HOMEOSTASIS; BLOOD-BRAIN-BARRIER; XENOBIOTIC RECEPTOR; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE;
D O I
10.1007/s11095-009-9901-7
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
The pregnane X receptor belongs to the nuclear hormone receptor superfamily and is involved in the transcriptional control of numerous genes. It was originally thought that it was a xenobiotic sensor controlling detoxification pathways. Recent studies have shown an increasingly important role in inflammation and cancer, supporting its function in abrogating tissue damage. PXR orthologs and PXR-like pathways have been identified in several non-mammalian species which corroborate a conserved role for PXR in cellular detoxification. In summary, PXR has a multiplicity of roles in vivo and is being revealed as behaving like a "Jekyll and Hyde" nuclear hormone receptor. The importance of this review is to elucidate the need for discovery of antagonists of PXR to further probe its biology and therapeutic applications. Although several PXR agonists are already reported, virtually nothing is known about PXR antagonists. Here, we propose the development of PXR antagonists through chemical, genetic and molecular modeling approaches. Based on this review it will be clear that antagonists of PXR and PXR-like pathways will have widespread utility in PXR biology and therapeutics.
引用
收藏
页码:1807 / 1815
页数:9
相关论文
共 132 条
[1]
The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency [J].
Acevedo, R ;
Parnell, PG ;
Villanueva, H ;
Chapman, LM ;
Gimenez, T ;
Gray, SL ;
Baldwin, WS .
JOURNAL OF APPLIED TOXICOLOGY, 2005, 25 (05) :339-353
[2]
Alterations in xenobiotic metabolism in the long-lived Little mice [J].
Amador-Noguez, Daniel ;
Dean, Adam ;
Huang, Wendong ;
Setchell, Kenneth ;
Moore, David ;
Darlington, Gretchen .
AGING CELL, 2007, 6 (04) :453-470
[3]
Anand PK, 2008, J MICROBIOL IMMUNOL, V41, P17
[4]
Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages [J].
Anand, PK ;
Kaul, D .
FEMS MICROBIOLOGY LETTERS, 2005, 250 (01) :137-144
[5]
Antebi A, 2000, GENE DEV, V14, P1512
[6]
A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver:: Inhibition of NF-κB? [J].
Axon, A. ;
Cowie, D. E. ;
Mann, D. A. ;
Wright, M. C. .
TOXICOLOGY, 2008, 246 (01) :40-44
[7]
PXR and the regulation of apoA1 and HDL-cholesterol in rodents [J].
Bachmann, K ;
Patel, H ;
Batayneh, Z ;
Slama, J ;
White, D ;
Posey, J ;
Ekins, S ;
Gold, D ;
Sambucetti, L .
PHARMACOLOGICAL RESEARCH, 2004, 50 (03) :237-246
[8]
Functional interactions between the Moses corepressor and DHR78 nuclear receptor regulate growth in Drosophila [J].
Baker, Keith D. ;
Beckstead, Robert B. ;
Mangelsdorf, David J. ;
Thummel, Carl S. .
GENES & DEVELOPMENT, 2007, 21 (04) :450-464
[9]
Rising standards for tuberculosis drug development [J].
Balganesh, Tanjore S. ;
Alzari, Pedro M. ;
Cole, Stewart T. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (11) :576-581
[10]
New small-molecule synthetic antimycobacterials [J].
Ballell, L ;
Field, RA ;
Duncan, K ;
Young, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2153-2163